Geode Capital Management
TRVI icon

Geode Capital Management’s Trevi Therapeutics TRVI Stock Holding History

Geode Capital Management’s Portfolio TRVI Stock Details TRVI Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$9.78M Buy
1,786,845
+171,980
+11% +$941K ﹤0.01% 2383
2025
Q1 		$10.2M Buy
1,614,865
+315,543
+24% +$1.99M ﹤0.01% 2285
2024
Q4 		$5.35M Buy
1,299,322
+35,156
+3% +$145K ﹤0.01% 2717
2024
Q3 		$4.22M Buy
1,264,166
+117,418
+10% +$392K ﹤0.01% 2848
2024
Q2 		$3.42M Buy
1,146,748
+248,783
+28% +$741K ﹤0.01% 2925
2024
Q1 		$3.1M Buy
897,965
+48,084
+6% +$166K ﹤0.01% 2935
2023
Q4 		$1.14M Buy
849,881
+62,241
+8% +$83.4K ﹤0.01% 3306
2023
Q3 		$1.72M Buy
787,640
+8,819
+1% +$19.2K ﹤0.01% 3123
2023
Q2 		$1.86M Buy
778,821
+530,528
+214% +$1.27M ﹤0.01% 3134
2023
Q1 		$459K Buy
248,293
+36,746
+17% +$68K ﹤0.01% 3673
2022
Q4 		$408K Buy
211,547
+11,326
+6% +$21.8K ﹤0.01% 3764
2022
Q3 		$308K Buy
200,221
+5,075
+3% +$7.81K ﹤0.01% 3972
2022
Q2 		$548K Buy
195,146
+122,402
+168% +$344K ﹤0.01% 3711
2022
Q1 		$160K Buy
72,744
+23,667
+48% +$52.1K ﹤0.01% 4478
2021
Q4 		$38K Hold
49,077
– – ﹤0.01% 4896
2021
Q3 		$67K Hold
49,077
– – ﹤0.01% 4749
2021
Q2 		$110K Hold
49,077
– – ﹤0.01% 4536
2021
Q1 		$133K Hold
49,077
– – ﹤0.01% 4233
2020
Q4 		$118K Hold
49,077
– – ﹤0.01% 4024
2020
Q3 		$197K Buy
49,077
+7,164
+17% +$28.8K ﹤0.01% 3728
2020
Q2 		$275K Hold
41,913
– – ﹤0.01% 3570
2020
Q1 		$137K Buy
41,913
+431
+1% +$1.41K ﹤0.01% 3660
2019
Q4 		$155K Hold
41,482
– – ﹤0.01% 3882
2019
Q3 		$186K Hold
41,482
– – ﹤0.01% 3798
2019
Q2 		$311K Buy
+41,482
New +$311K ﹤0.01% 3637